No Benefit of Hypomethylating Agents Compared to Supportive Care for Higher Risk Myelodysplastic Syndrome by IPSS-R. (April 2017) - Lee, Y.; Sohn, S.; Ahn, J.; Kim, H.J.; Shin, H.J.; Lee, H.S.; Suh, J.; Do, Y.R.; Kim, B.S.